Angela Muri
Psychiatric/Mental Health · Duncansville, PANPI 1346838695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 283 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 44.6% of the total. 2025 is the largest year on record at $2,923, more than ten times the $25 reported in 2021. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$568
- Alkermes, Inc.$259
- Takeda Pharmaceuticals U.S.A., Inc.$258
- Johnson & Johnson$245
- Teva Pharmaceuticals USA, Inc.$229
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,672100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 149 | $2,082 |
| Otsuka America Pharmaceutical, Inc. | 33 | $568 |
| Alkermes, Inc. | 13 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $258 |
| Johnson & Johnson | 11 | $245 |
| Teva Pharmaceuticals USA, Inc. | 13 | $229 |
| Lundbeck LLC | 11 | $219 |
| Axsome Therapeutics, Inc. | 8 | $162 |
| Indivior Inc. | 7 | $143 |
| E.r. Squibb & Sons, L.L.C. | 5 | $114 |
| Neurocrine Biosciences, Inc. | 6 | $114 |
| Novo Nordisk | 5 | $93 |
| Inspire Medical Systems, Inc. | 1 | $60 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Almatica Pharma LLC | 1 | $20 |
| Neuronetics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$113
How this compares
$4,672 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 21 | $550 |
| Duloxetine Hcl | 14 | $530 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $293 |
| Trazodone Hcl | 12 | $182 |
| Fluoxetine Hcl | 17 | $149 |
| Buspirone Hcl | 12 | $91 |
| Aripiprazole | 11 | $89 |
| Clonazepam | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Duncansville
- Laura OfarrellDuncansville$20K
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.